Connect
MJA
MJA

Epidemiology of syphilis in Australia: moving toward elimination of infectious syphilis from remote Aboriginal and Torres Strait Islander communities?

James S Ward, Rebecca J Guy, Snehal P Akre, Melanie G Middleton, Carolien M Giele, Jiunn Y Su, Craig A Davis, Handan Wand, Janet B Knox, Patricia S Fagan, Basil Donovan, John M Kaldor and Darren B Russell
Med J Aust 2011; 194 (10): 525-529. || doi: 10.5694/j.1326-5377.2011.tb03089.x
Published online: 16 May 2011

Abstract

Objective: To describe the epidemiology of infectious syphilis among Aboriginal and Torres Strait Islander (Indigenous) people in Australia.

Design and setting: We assessed trends in national infectious syphilis notification rates from 2005 to 2009 using Poisson regression, with a focus on geographic and demographic differences by Indigenous status. We compared Indigenous and non-Indigenous rate ratios over the study period and summarised the annual changes (summary rate ratio).

Main outcome measures: Crude notification rates and summary rate ratios by Indigenous status, jurisdiction, sex, age group and area of residence.

Results: From 2005 to 2009, in the Indigenous population, there was a substantial decline in the notification rate for infectious syphilis nationally; as well as in the following subgroups: females, 15–29 year olds, and people living in outer regional and remote areas in the Northern Territory and Queensland. In contrast, there was a significant (P < 0.001) upward trend in the notification rate in the non-Indigenous population nationally; as well as in males, in people aged 20 years and over, and in residents of metropolitan and regional areas, New South Wales, Queensland, South Australia, Victoria and Western Australia. The highest summary rate ratios were seen in remote/very remote areas (86.33; 95% CI, 57.45–129.74), in 15–19 year olds (64.65; 95% CI, 51.12–81.78), in females (24.59; 95% CI, 19.73–30.65), and in Western Australia (23.89; 95% CI, 19.82–28.82).

Conclusion: These data demonstrate that Australia has two distinct patterns of infectious syphilis: a substantially declining occurrence in Indigenous remote communities and an increasing incidence in males residing in urban and regional areas. Given the decline in notification rates in Indigenous remote communities, now might be the right time to move toward eliminating infectious syphilis from Indigenous communities.

Syphilis is a sexually transmissible infection (STI) caused by Treponema pallidum. It is treatable with standard antibiotics,1 but in the absence of therapy, gives rise to sequential clinical stages. In the initial stages, the infection is highly transmissible and often presents as ulcerative genital lesions or a rash. Infectiousness diminishes through a long latency period, which may be followed by serious complications including cardiovascular and neurological disease.1 Syphilis can be passed on during pregnancy to the developing fetus and frequently causes miscarriage, stillbirth, neonatal death or serious consequences such as deafness, blindness and mental retardation.2

Syphilis is a legally notifiable infection in all states and territories. Since 2004, new diagnoses that are determined on the basis of laboratory and clinical information to be in the early, infectious stage (less than 2 years’ duration)3 have been reported by all Australian states and territories to the National Notifiable Diseases Surveillance System, with information on patient demographics.4

Historically, the reported rates of infectious syphilis have been much higher among Aboriginal and Torres Strait Islander (Indigenous) people than in non-Indigenous Australians. Indigenous Australians residing in remote communities are particularly affected.4 There have been sustained efforts to control syphilis in this population using clinical strategies based on population screening, in combination with preventive strategies. These measures have had some success;5-7 however, there remains considerable disparity between Indigenous and non-Indigenous Australians.

We analysed national infectious syphilis notification data by Indigenous status to guide future policy and prevention strategies.

Methods

Our analyses use data on infectious syphilis reported to the National Notifiable Diseases Surveillance System from 2005 to 2009. Indigenous status is reported as Aboriginal, Torres Strait Islander or both. Notifications where Indigenous status was not reported were excluded from the analysis.

Results

A total of 5525 cases of infectious syphilis were reported nationally between 2005 and 2009, including 189 cases for which Indigenous status was not reported. Based on 123 notifications in 2009 in the Indigenous population, the overall crude notification rate per 100 000 population was 31 in 2005, 40 in 2006, decreasing to 25 in 2009, with a significant downward trend observed over the 5-year period (P < 0.001).

In contrast, for the 1159 notifications reported in 2009 in the non-Indigenous population, there was a significant upward trend in the crude infectious syphilis rate from two in 2005 to six in 2009 (P < 0.001).

The summary rate ratio for Indigenous v non-Indigenous people was 7.91 (P < 0.001) (Box 1).

Discussion

Australia has two distinct patterns of infectious syphilis.

The increasing rates in the non-Indigenous population occur mostly (but not exclusively) in males and are predominantly reported among men who have sex with men (MSM).10-14 Due to the absence of a reliable denominator, it is not possible to calculate the population rates for this population. However, given that 90% of male non-Indigenous cases occur among MSM, and that MSM are estimated to make up about 2% of the total male population,15 the crude rate among MSM would match the highest rates seen in young Indigenous people in remote settings.

The downward trend in infectious syphilis rates seen in Indigenous people commenced in 2006. Only in WA was there an upward trend. This could be due to a change of reporting procedures in June 2006, whereby notifications of syphilis cases from laboratories became mandatory rather than voluntary, or to a well defined outbreak of syphilis infection identified in a remote region of WA in 2008.16

By 2009, notification rates in Indigenous people aged 15–19 years were at a level below all other age groups, excluding the ≥ 40 years group. This may be a consequence of people aged over 40 years missing out on the benefit of annual screening rounds, which generally target people aged 15–35 years.17

The significant decrease in notifications of infectious syphilis seen in Indigenous people between 2005 and 2009 might be attributable to a decline in testing and case finding. However, available testing data suggest the opposite. For example, in far north Queensland, the number of syphilis tests increased from 4054 tests in 2004 to 6199 in 2005,18 and the implementation of a Young Persons Check in remote communities since early 2009 has increased levels of syphilis testing in target age groups. In central Australia and cross-border regions of WA, NT and South Australia, high rates of testing achieved through annual community STI screening programs have been sustained during the study period.6,17 Nationally, antenatal screening is seen as an important contributor to reductions in infectious syphilis notifications, with fewer than 10 cases of congenital syphilis diagnosed annually since 2007.19

An alternative explanation for the observed decreasing trend in infectious syphilis notification rates in the Indigenous population is a real decrease in incidence achieved through population screening and case management. Centrally based state-wide syphilis registers, staffed by specialists and specifically trained nurse consultants, have improved case management by providing testing, treatment and management advice to clinicians for infectious and congenital syphilis.17

Other factors possibly contributing to the observed decrease in infectious syphilis include incidental treatment of early syphilis due to increasing use of antibiotics, such as azithromycin, for treatment of other common infections, including bacterial STIs. While single doses of oral azithromycin or amoxicillin plus probenecid are not recommended as treatment for syphilis, both are recommended as second-line treatments for syphilis in people with penicillin allergies.20,21 The reduction in the absolute numbers of infectious syphilis cases from 233 in 2006 to 123 in 2009, combined with the relative geographical concentration of cases in remote communities, provides the opportunity to consider whether a renewed and strengthened emphasis on intervention may actually eliminate infectious syphilis from this population.

In Australia, a recently endorsed national strategy22 recognises this potential. At the community level, the goal of elimination has already been shown to be feasible. For example, the STI program in the Anangu Pitjantjatjara Yankunytjatjara Lands of SA, coordinated by Nganampa Health Council, has achieved a significant reduction in infectious syphilis prevalence over the past 11 years using the Eight Way Model.6,23 This model incorporates clinical activities, such as screening and opportunistic testing and treatment, combined with project planning and management, staff training, community-based education and health promotion, health hardware (including condom provision), research, surveillance, and monitoring and evaluation.

A factor that gives cause for optimism in contemplating the elimination of infectious syphilis from remote communities is that those communities appear to have sexual networks that are relatively separate from non-Indigenous populations. Notably, antibiotic resistance in Neisseria gonorrhoeae is only just emerging in remote communities, even though it has been widespread in non-Indigenous people for over 25 years.24 However, it is recognised that cases associated with male-to-male sex do occur among men who also have sex with women, highlighting the potential for onward transmission in Indigenous communities.

The central Australian donovanosis project of 1997 and the National Donovanosis Eradication Project implemented in 2000 further support the notion that elimination of syphilis is achievable within Indigenous remote communities. The Donovanosis Eradication Project employed four project officers in northern Australia who provided health services with support, including education and centralised coordination to assist case-finding and management.25 This led to significant decreases in donovanosis diagnoses, from 121 cases in 1994 to 32 cases in 2001; in 2009, only one case was identified in Australia.3,25,26 However, T. pallidum is an extremely infectious organism that can be transmitted without symptoms; it may therefore be more difficult to eliminate than donovanosis.1

A limitation to our study is that, in many remote communities, the clinical information required to classify a syphilis diagnosis as infectious syphilis is sometimes not available. This means that some cases may be wrongly classified as non-infectious. An analysis of trends in non-infectious syphilis notifications shows a similar downward trend (data not shown). Also limiting our study was the lack of access to data on systematic syphilis testing from all Indigenous communities. These data would have enabled us to confirm whether rates of testing have changed at a population level.

Now might be the right time to move toward the elimination of infectious syphilis from remote Indigenous communities. The relatively small numbers of notifications, their geographical concentration and recent sustained decreases, make this aim a viable option. Achieving this would remove another disparity in health between Indigenous and non-Indigenous Australians.

1 Infectious syphilis notifications in 2009, and average annual trends and summary rate ratios for 2005–2009, by Indigenous status, age group, sex, area of residence and jurisdiction

Indigenous


Non-Indigenous


Indigenous v non-Indigenous


Cases in 2009

Average annual trend, 2005–2009

95% CI

Cases in 2009

Average annual trend, 2005–2009

95% CI

Summary rate ratio, 2005–2009

95% CI


Total

123

0.93*

0.89–0.97

1159

1.22*

1.20–1.25

7.91*

7.38–8.48

Age group (years)

15–19

17 (14.1%)

0.84*

0.77–0.92

21 (1.8%)

1.12

0.97–1.29

64.65*

51.12–81.78

20–29

43 (35.5%)

0.91 

0.84–0.98

286 (24.7%)

1.28*

1.22–1.33

11.23*

9.93–12.71

30–39

35 (28.9%)

0.97 

0.88–1.08

329 (28.4%)

1.17*

1.13–1.21

4.97

4.25–5.81

40 +

26 (21.5%)

1.07 

0.95–1.21

523 (45.1%)

1.26*

1.22–1.30

5.24*

4.39–6.25

Sex

Males

74 (60.1%)

0.97

0.92–1.04

1094 (94.4%)

1.23*

1.21–1.26

4.27

3.88–4.69

Females

49 (39.9%)

0.87

0.82–0.93

65 (5.6%)

1.12

0.97–1.29

24.59

19.73–30.65

Area of residence

Metropolitan

15 (12.2%)

1.09

0.94–1.27

1015 (91.1%)

1.16

0.87–1.54

2.00*

1.62–2.48

Inner regional

5 (4.1%)

0.82

0.66–1.02

71 (6.4%)

1.29*

1.14–1.45

7.00*

5.06–9.66

Outer regional

27 (22.0%)

0.87*

0.77–0.98

31 (2.8%)

1.19*

1.10–1.30

18.81*

14.87–23.79

Remote/very remote

75 (61.0%)

0.92*

0.88–0.98

6 (0.1%)

1.24*

1.21–1.27

86.33*

57.45–129.74

Unknown

1 (0.8%)

36 (3.1%)

Jurisdiction

NSW

12 (9.8%)

1.10 

0.89–1.35

510 (44.0%)

1.22*

1.18–1.27

1.05

0.78–1.41

NT

37 (30.1%)

0.81*

0.76–0.87

1 (0.1%)

1.02

0.83–1.27

3.18*

2.87–3.50

Qld

32 (26.0%)

0.83*

0.75–0.93

148 (12.8%)

1.10*

1.05–1.16

6.71*

5.70–7.89

SA

7 (5.7%)

1.00

0.81–1.24

46 (4.0%)

1.25*

1.12–1.39

2.59*

2.26–2.93

Tas

0

11 (0.9%)

1.18

0.93–1.49

Vic

1 (0.8%)

0.79

0.58–1.08

389 (33.6%)

1.27*

1.22–1.31

2.20*

1.44–3.35

WA

34 (27.6%)

1.31*

1.18–1.45

54 (4.7%)

1.44*

1.31–1.59

23.89 

19.82–28.82


NSW = New South Wales. NT = Northern Territory. Qld = Queensland. SA = South Australia. Tas = Tasmania. Vic = Victoria. WA = Western Australia.
* P < 0.001.
Excludes two patients aged < 15 years.

  • James S Ward1
  • Rebecca J Guy1
  • Snehal P Akre1
  • Melanie G Middleton1
  • Carolien M Giele2
  • Jiunn Y Su3
  • Craig A Davis4
  • Handan Wand1
  • Janet B Knox1
  • Patricia S Fagan5
  • Basil Donovan1
  • John M Kaldor1
  • Darren B Russell6,7

  • 1 Kirby Institute (formerly National Centre in HIV Epidemiology and Clinical Research), University of New South Wales, Sydney, NSW.
  • 2 Communicable Disease Control Directorate, Public Health Division, WA Department of Health, Perth, WA.
  • 3 Centre for Disease Control, Department of Health and Families, Darwin, NT.
  • 4 Health Protection Directorate, Division of the Chief Health Officer, Queensland Health, Brisbane, QLD.
  • 5 Tropical Regional Services, Queensland Health, Cairns, QLD.
  • 6 James Cook University, Townsville, QLD.
  • 7 Cairns Sexual Health Centre, Queensland Health, Cairns, QLD.


Correspondence: jward@kirby.unsw.edu.au

Competing interests:

None identified.

  • 1. Donovan B, Dayan L. Syphilis. In: Warrell DA, Cox TM, Firth JD, editors. Oxford textbook of medicine. Oxford: Oxford University Press, 2010: 885-896.
  • 2. Schmid GP, Stoner BP, Hawkes S, et al. The need and plan for global elimination of congenital syphilis. Sex Transm Dis 2007; 34: S5-S10.
  • 3. Australian Government Department of Health and Ageing. Australian national notifiable diseases case definitions. Syphilis — infectious (primary, secondary and early latent), less than 2 years duration case definition. http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-casedefs-cd_syphl2.htm (accessed Oct 2010).
  • 4. National Centre in HIV Epidemiology and Clinical Research. Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait Islander people. Surveillance and evaluation report 2009. Sydney: University of New South Wales, 2009.
  • 5. Miller PJ, Torzillo P, Tizard J, et al. Interventions to reduce the interval to treatment in syphilis: central case management and encrypted email. Venereology 1998; 11: 26-29.
  • 6. Mak D, Johnson G, Plant A. A syphilis outbreak in remote Australia: epidemiology and strategies for control. Epidemiol Infect 2004; 132: 805-812.
  • 7. Huang R-L, Torzillo PJ, Hammond VA, et al. Epidemiology of sexually transmitted infections on the Anangu Pitjantjatjara Yankunytjatjara Lands: results of a comprehensive control program. Med J Aust 2008; 189: 442-445. <MJA full text>
  • 8. McGrail MR, Humphreys JS. Geographical classifications to guide rural health policy in Australia. Aust N Z Health Policy 2009; 6: 28.
  • 9. Australian Bureau of Statistics. Experimental estimates and projections, Aboriginal and Torres Strait Islander Australians, 1991 to 2021. Canberra: ABS, 2009. (ABS Cat. No. 3238.0.)
  • 10. Jin F, Prestage GP, Zablotska I, et al. High incidence of syphilis in HIV-positive homosexual men: data from two community-based cohort studies. Sex Health 2009; 6: 281-284.
  • 11. National Centre in HIV Epidemiology and Clinical Research. HIV, viral hepatitis and sexually transmissible infections in Australia. Annual surveillance report 2010. Sydney: University of New South Wales, 2010.
  • 12. Allen K, Guy R, Leslie D, et al. The rise of infectious syphilis in Victoria and the impact of enhanced clinical testing. Aust N Z J Public Health 2008; 32: 39-42.
  • 13. Guy RJ, Leslie DE, Simpson K, et al. Sustained increase in infectious syphilis notifications in Victoria. Med J Aust 2005; 183: 218. <MJA full text>
  • 14. Jin F, Prestage GP, Kippax SC, et al. Epidemic syphilis among homosexually active men in Sydney. Med J Aust 2005; 183: 179-183. <MJA full text>
  • 15. Prestage GP, Ferris J, Grierson J, et al. Homosexual men in Australia: population, distribution and HIV prevalence. Sex Health 2008; 5: 97-102.
  • 16. Government of Western Australia Department of Health. Disease Watch: the Western Australian Communicable Diseases Bulletin 2010; 14(2). http://www.public.health.wa.gov.au/cproot/3156/2/DW_14_no_2_Jun_2010_web.pdf (accessed Apr 2011).
  • 17. Smith K, Fethers K, Tangey A, et al. Sexually transmitted infections (STIs) in Central Australia — time for concerted action. Proceedings of the Australasian Sexual Health Conference; 2006 Oct 9-11; Melbourne, Australia.
  • 18. Fagan PS, Cannon FM. Syphilis in remote north Queensland. Commun Dis Intell 2007; 31: 125-127.
  • 19. NNDSS Annual Report Writing Group. Australia’s notifiable status, 2007. Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2009; 33: 89-154.
  • 20. Workowski KA, Berman S; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59 (RR-12): 1-110.
  • 21. Klausner JD, Kohn RP, Kent CK. Azithromycin versus penicillin for early syphilis. N Engl J Med 2006; 354: 204.
  • 22. Australian Government Department of Health and Ageing. Third National Aboriginal and Torres Strait Islander Blood Borne Viruses and Sexually Transmissible Infections Strategy 2010–2013. Canberra: Commonwealth of Australia, 2010. http://www.health.gov.au/internet/main/publishing.nsf/Content/ohp-national-strategies-2010-atsi-bbv/$File/atsi.pdf (accessed Apr 2010).
  • 23. Sexual Health and Blood-borne Virus Program. Western Australian Aboriginal Sexual Health Strategy 2005–2008. Perth: WA Department of Health, 2005.
  • 24. Australian Gonococcal Surveillance Programme. Annual report 2009. Commun Dis Intell 2010; 34: 89-95.
  • 25. Australian Government Department of Health and Ageing. National Notifiable Diseases Surveillance System. Number of notifications of donovanosis, Australia, 1991 to present. http://www9.health.gov.au/cda/Source/CDA-index.cfm (accessed Oct 2010).
  • 26. Bowden F, on behalf of the National Donovanosis Eradication Advisory Committee. Donovanosis in Australia: going, going... Sex Transm Infect 2004; 81: 365-366.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.